INBS Intelligent Bio Solutions
- 2.410
- +0.070+2.99%
- 2.770
- +0.360+14.94%
Intelligent Bio Solutions News
Intelligent Bio Solutions Q3 EPS $(1.43) Beats $(2.52) Estimate
Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly losses of $(1.43) per share which beat the analyst consensus estimate of $(2.52) by 43.25 percent. This is a 97.92 percent increase over loss
Intelligent Bio Solutions | 10-Q: Quarterly report
Earnings Flash (INBS) INTELLIGENT BIO SOLUTIONS Reports Q3 Revenue $823,800
08:31 AM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (INBS) INTELLIGENT BIO SOLUTIONS Reports Q3 Revenue $823,800
Express News | Intelligent Bio Solutions Q3 Basic EPS USD -1.43
Express News | Intelligent Bio Solutions Q3 Net Income USD -2.98 Million
Express News | Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights
Press Release: Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights
Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights Year-over-year revenue increased 80% for the fiscal third quarter and 193%
Intelligent Bio Solutions 3Q Loss $2.99M >INBS
Intelligent Bio Solutions 3Q Loss $2.99M >INBS
Intelligent Bio Solutions 3Q Rev $823,800 >INBS
Intelligent Bio Solutions 3Q Rev $823,800 >INBS
Intelligent Bio Solutions 3Q Loss/Shr $1.43 >INBS
Intelligent Bio Solutions 3Q Loss/Shr $1.43 >INBS
Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter And Nine-Month Financial Results and Operational Highlights
Year-over-year revenue increased 80% for the fiscal third quarter and 193% for the nine months ended March 31, 2024Cash and cash equivalents as of March 31, 2024, was $9.40 millionCommenced FDA 510(k)
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersChromocell Therapeutics (AMEX:CHRO) stock increased by 21.6% to $1.49 during Friday's pre-market session. The company's market cap stands at $8.7 million. Kineta (NASDAQ:KA) stock moved upwards
Intelligent Bio Solutions Reports Preliminary Unaudited Fiscal Q3 Results
Express News | Intelligent Bio Solutions Sees Prelim. Q3 2024 Revenue $0.82M Vs $1.190M Est
Intelligent Bio Solutions Sees 3Q Rev of Around $820,000>INBS
Intelligent Bio Solutions Sees 3Q Rev of Around $820,000>INBS
Express News | Intelligent Bio - Cartridge and Reader Sales Are Expected to Increase 25% and 63%, Respectively, From July 1, 2023, Through to March 31, 2024
Express News | Intelligent Bio Solutions Inc - Sees Qtrly Year-Over-Year Increase of 17% in Cartridge Sales
Express News | Intelligent Bio Solutions Inc - Expects Approximate Unaudited Revenue of $0.82 Mln for Three Months Ended March 31, 2024
Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Results
Year-over-year unaudited revenue increased 80% for the fiscal third quarter and 193% for the nine months ended March 31, 2024, with highest quarterly cartridge sales since 2022 Intelligent Fingerprint
Express News | Intelligent Bio Solutions Subsidiary Fingerprinting Granted New European Patent With Unitary Effect For DSR-Plus Cartridge Reader
Analysis
Price Target
No Data
